ecrin-mdr-crcClinical2009Metastatic Colorectal CancerColorectal carcinomaBehandlingsresistente patienter med metastaserende colorectal cancer og KRAS mutationerColorectal NeoplasmsColorectal CarcinomaMetastatic Colorectal CancerColorectal NeoplasmsBehandlingsresistente Patienter Med Metastaserende Colorectal Cancer Og Kras MutationerInterventionalhttps://newmdr.ecrin.org/Study/2066730Denmark3IrinotecanKRAS mutationIrinotecan "Mayne"MTOR InhibitorsSirolimusTemsirolimusECRIN MDRCompletedfalseTemsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsThe purpose of this study is to investigate the safety and efficacy of temsirolimus as a single drug, and of temsirolimus in combination with irinotecan in chemotherapy resistant patients with KRAS mutated colorectal cancer.2009-03-152066730NCT008276842008-007665-22